Agenus Inc (AGEN) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Over the past 4 years, Agenus Inc has achieved a revenue compound annual growth rate (CAGR) of 34.9%, while earnings have grown at 6.2% CAGR.
Historical revenue and profitability trends for Agenus Inc
The chart above illustrates Agenus Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Agenus Inc's business.
How efficiently Agenus Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Agenus Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Agenus Inc to continue focusing on sustainable operations. The consensus analyst rating is 3.6 based on 5 analysts.
Based on our comprehensive analysis, Agenus Inc (AGEN) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Agenus Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Agenus Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: AGEN Valuation, AGEN Dividend, AGEN Financial Health
Compare: AGEN vs AAPL, AGEN vs MSFT, AGEN vs GOOGL